References
- Moertel C G. Current concepts in cancer, chemotherapy of gastrointestinal cancer. N Engl J Med 1978; 199: 1049–1052
- Lavin P, Mittelman A, Douglass H, et al. Survival and response to chemotherapy for advanced colorectal adenocarcinoma. Cancer 1980; 46: 1536–1543
- Bedikian A Y, Bodey G P, Valdivieso M, . Chemotherapeutic management of colorectal cancer and prospects for new agents. Gastrointestinal Cancer, J R Stroehlein, M M Rausdohl, et al. Raven Press, New York 1985; 365–380
- Ullman B, Lee M, Martin D W, Jr, et al. Cytotoxicity of 5-fluoro-2 deoxyuridine: requirement for reduced folate cofactors and antagonism by methotrexate. Proc Natl Acad Sci (USA) 1978; 75: 980–983
- Santi D V. A biochemical rationale for the use of 5-fluorouracil in combination with leucovorin. An update Advances in Cancer Chemotherapy. The Current Status of 5-Fluorouracil-Leucovorin Calcium Combination, H W Bruckner, Y M Rustum. Park Row, New York 1984; 1–6
- Bruckner H W, Roboz J, Spigelman M, . An efficient leucovorin-5-fIuorouracil sequence: dosage escalation and pharmacology monitoring. An update. Advances in Cancer Chemotherapy. The Current Status of 5-Fluorouracil-Leucovorin Calcium Combination, H W Bruckner, Y M Rustum, et al. Park Row, New York 1984; 49–54
- Machover D, Schwarzenberg L, Goldschmidt E, et al. Treatment of advanced colorectal cancer and gastric adenocarcinomas with 5-FU combined with high doses of folinic acid: A pilot study. Cancer Treat Rep 1982; 66: 1803–1807
- Machover D, Goldshmidt E, Chollet P, et al. Treatment of advances colorectal and gastric adenocarcinomas with 5-fluorouracil and high dose folinic acid. J Clin Oncol 1986; 4: 685–696
- Byrne P J, Treat J, McFadden M, . Therapeutic efficacy of the combination of 5-fluorouracil and high-dose leucovorin in patients with advanced colorectal carcinoma single daily intravenous dose for five days. An update. Advances in Cancer Chemotherapy, The Current Status of 5-Fluorouracil-Leucovorin Calcium Combination, H W Bruckner, Y M Rustum, et al. Park Row, New York 1984; 65–68
- Bukowski R M, Cunningham J. Efficacy of 5-fluorouracil in combination with leucovorin in patients with colorectal carcinoma: continuous infusion of low doses. An update. Advances in Cancer Chemotherapy. The Current Status of 5-Fluorouracil-Leucovorin Calcium Combination, H W Bruckner, Y M Rustum. Park Row, New York 1984; 69–72
- Cunningham J, Bukowski R M, Budd G T, et al. 5-Fluorouracil and folinic acid:phase III trial. Invest New Drugs 1984; 2: 391–395
- Nobile M T, Sertoli M R, Bruzzone M, et al. Phase II study with high dose N5–10 methyltetrahydrofolate and 5-fluorouracil in advanced colorectal cancer. Eur J Cancer Clin Oncol 1985; 21: 1175–1177
- Madajewicz S, Petrelli N, Rustum M Y, et al. Phase I-II trial of high dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer. Cancer Res 1984; 44: 4667–4669
- Bertrand M, Doroshow J H, Multhauf P, et al. High-dose continuous infusion folinic acid and bolus 5-fluorouracil in patients with advanced colorectal cancera phase II study. J Clin Oncol 1986; 4: 1058–1061
- Moertel C G, Schutt A J, Hahm R G, et al. Effect of patient selection on results of phase II chemotherapy trial in gastrointestinal cancer. Cancer Chemother Rep 1974; 58: 257–259
- Miller A B, Hoogstraten B, Staquet M, et al. Reporting results in cancer treatment. Cancer 1981; 47: 207–214
- Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumors of the liver I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer 1969; 23: 198–202
- Wood C B, Gillis C R, Blungart L H. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 1976; 2: 285–288
- Lahr C J, Soong S J, Cloud G, et al. A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. J Clin Oncol 1983; 1: 221–238